Skip to content
healthcare.dev

Mestinon

NDC 0187-3013, pyridostigmine bromide, tablet, extended release, from Bausch Health US, LLC.

Product NDC
0187-3013
Status
Listed
Labeler
Bausch Health US, LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA011665
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0187-3013 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PYRIDOSTIGMINE BROMIDE180 mg/1

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
0187-3013-300018730133030 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-3013-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a851795e-b7a8-40c3-9922-5e79d3eb4d92

Use it

Look up 0187-3013 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0187-3013 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0187-3013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.